Iowa’s great cancer mystery: Is the land making young people sick?

WINTERSET, Iowa - Mackenzie Dryden’s happiest childhood memories are of running barefoot through the sunlit corn fields of her hometown. But when she was diagnosed with cancer 2½ years ago at 18 years ...

Metabo HPT Launches “Bring Back Shop Class” Campaign to Equip Next Generation for the Trades

Power tool brand partners with Shop Class Foundation to reignite America’s skilled labor workforce, releases new national survey dataBRASELTON, Ga., Oct. 27, 2025 (GLOBE NEWSWIRE) -- As America faces ...

Tolerance Bio’s Implanted iPSC-derived Thymic Organoids Enable In Vivo Positive Selection of Human T cells and Tumor Burden Reduction in Melanoma

Tolerance Bio, a biopharmaceutical company pioneering innovative approaches to extending healthspan by preserving, restoring, ...
Le Lézard

TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn's disease at two years

Johnson & Johnson today announced new 96-week data from the long-term extensions (LTE) of the Phase 3 GRAVITI, GALAXI 2 and GALAXI 3 studies, which show the durability of TREMFYA® (guselkumab) in ...
Le Lézard

Ferring Presents New Data Analyses for REBYOTA® (fecal microbiota, live ? jslm) at ACG 2025

Ferring Pharmaceuticals today shared an oral presentation detailing microbiome restoration from the Phase 3b CDI-SCOPE study among patients with recurrent C. difficile (C. diff) infection (CDI) who ...